SPONSORED CONTENT

PrevestDenpro - a force to reckon in dental healthcare sector

December 27, 2021 23:30 IST | ANI Press Release
Tennis player James Blake
PrevestDenpro

New Delhi [India], December 27 (ANI/GIPR): In the midst of a coronavirus-caused Covid-19 pandemic when many companies are struggling to make ends meet, there are some companies that have become a force to reckon with and to bet on without getting into any kind of financial hassles - PrevestDenpro, one of India's leading manufacturers of dental materials, is one of them.

PrevestDenpro is addressing USD 20 billion global market growing at 8% CAGR with products which find applications in endodontics, prosthodontics, orthodontics, restorative dentistry, aesthetic dentistry trusted by dental professionals across the world in more than 75 countries with the most enviable financials.

But what caught the attention of RH Perennial Fund is the potential hyper scaling over next 3-4 years.

PrevestDenpro: Business Portfolio - Stupendous Growth Expected

"The business pre-IPO had a gross block of INR 8 crores and turnover of 27.5 cr. It raised ~INR 26 crores from its IPO with INR 16 crores for new capex. Essentially if the management executes over the next 3-4 years, it could more than triple its revenues in an industry where the company has a gross margins more than 70%, says RH Perennial Fund report.

PrevestDenpro: Exponential Growth So Far

Over the past 5 years, the company has shown exponential growth in revenue & profitability with 5 year revenue/PAT CAGR of 21% & 57%, gross profit margins above 70%, negative cash conversion cycle & ROCE above 40%, and negligible debt.

PrevestDenpro: Key Growth Drivers

- Huge size of opportunity & attractive industry structure - The business is addressing USD 19.3 billion global dental market growing at 8% CAGR & USD 700 million Indian market growing at 7% where most players display excellent unit economics & value creation overtime

- The Company has obtained USFDA approval for five dental products and has applied for MDSAP certification that will open the doors for Canadian and Brazilian market besides USA.

- PrevestDenpro: How fastest-growing company in the dental healthcare sector tookbirth?

- PrevestDenpro was founded in the year 1999 by Jammu based entrepreneurs Atul Modi and Namrata Modi, who now cumulatively possess over 42 years of experience in the dental industry.

- They sell products through a network of 53 dealers spread over 16 states and 2 Union Territories in India and through 91 overseas agents spread over 75 countries.

- They primarily follow a business-to-business model for all their dental products. Further, they have started selling certain of their products to direct consumers on digital market platforms such as Amazon and their own web-platform i.e.prevestdirect.com.

- As on date, they have collaboration with five reputed dental universities and institutions of India for the exchange of technical knowledge and conducting training & research on dental materials. Also, they have entered into a license agreement with Sree Chitra Tirunal Institute for Medical Sciences & Technology, Kerala for obtaining the know-how and rights to enable them to manufacture bioactive bone augmentation materials.

- Their products are certified with ISO 13485:2016, EU CE mark & US FDA, which makes them eligible to market their products in European Union and many other countries which have adopted EU medical devices directives.

- Future Growth Drivers - a well diversified business plan supported by state-of-the-art research centre under implementation, extensive marketing and brand promotion activities planned will help the company to grow exponentially in the coming times.

This story is provided by GIPR. ANI will not be responsible in any way for the content of this article. (ANI/GIPR)

DISCLAIMER


(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

 

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

PrevestDenpro - a force to reckon in dental healthcare sector

New Delhi [India], December 27 (ANI/GIPR): In the midst of a coronavirus-caused Covid-19 pandemic when many companies are struggling to make ends meet, there are some companies that have become a force to reckon with and to bet on without getting into any kind of financial hassles - PrevestDenpro, one of India's leading manufacturers of dental materials, is one of them.

PrevestDenpro is addressing USD 20 billion global market growing at 8% CAGR with products which find applications in endodontics, prosthodontics, orthodontics, restorative dentistry, aesthetic dentistry trusted by dental professionals across the world in more than 75 countries with the most enviable financials.

But what caught the attention of RH Perennial Fund is the potential hyper scaling over next 3-4 years.

PrevestDenpro: Business Portfolio - Stupendous Growth Expected

"The business pre-IPO had a gross block of INR 8 crores and turnover of 27.5 cr. It raised ~INR 26 crores from its IPO with INR 16 crores for new capex. Essentially if the management executes over the next 3-4 years, it could more than triple its revenues in an industry where the company has a gross margins more than 70%, says RH Perennial Fund report.

PrevestDenpro: Exponential Growth So Far

Over the past 5 years, the company has shown exponential growth in revenue & profitability with 5 year revenue/PAT CAGR of 21% & 57%, gross profit margins above 70%, negative cash conversion cycle & ROCE above 40%, and negligible debt.

PrevestDenpro: Key Growth Drivers

- Huge size of opportunity & attractive industry structure - The business is addressing USD 19.3 billion global dental market growing at 8% CAGR & USD 700 million Indian market growing at 7% where most players display excellent unit economics & value creation overtime

- The Company has obtained USFDA approval for five dental products and has applied for MDSAP certification that will open the doors for Canadian and Brazilian market besides USA.

- PrevestDenpro: How fastest-growing company in the dental healthcare sector tookbirth?

- PrevestDenpro was founded in the year 1999 by Jammu based entrepreneurs Atul Modi and Namrata Modi, who now cumulatively possess over 42 years of experience in the dental industry.

- They sell products through a network of 53 dealers spread over 16 states and 2 Union Territories in India and through 91 overseas agents spread over 75 countries.

- They primarily follow a business-to-business model for all their dental products. Further, they have started selling certain of their products to direct consumers on digital market platforms such as Amazon and their own web-platform i.e.prevestdirect.com.

- As on date, they have collaboration with five reputed dental universities and institutions of India for the exchange of technical knowledge and conducting training & research on dental materials. Also, they have entered into a license agreement with Sree Chitra Tirunal Institute for Medical Sciences & Technology, Kerala for obtaining the know-how and rights to enable them to manufacture bioactive bone augmentation materials.

- Their products are certified with ISO 13485:2016, EU CE mark & US FDA, which makes them eligible to market their products in European Union and many other countries which have adopted EU medical devices directives.

- Future Growth Drivers - a well diversified business plan supported by state-of-the-art research centre under implementation, extensive marketing and brand promotion activities planned will help the company to grow exponentially in the coming times.

This story is provided by GIPR. ANI will not be responsible in any way for the content of this article. (ANI/GIPR)

DISCLAIMER


(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22